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Abstract
IMPORTANCE In observational studies, patients’ treatment outcome expectations have been
associated with better outcomes (ie, a placebo response), whereas concerns about adverse side
effects have been associated with an in increase in the negative effects of treatments (ie, a nocebo
response). Some randomized trials have suggested that communication from clinicians could affect
the treatment outcomes by changing patients’ expectations.
OBJECTIVE To investigate whether treatment outcome expectations and reported adverse side
effects could be affected by different briefing contents before a minimal acupuncture treatment in
patients with chronic low back pain (CLBP).
DESIGN, SETTING, ANDPARTICIPANTS This randomized single-blinded clinical trial was
conducted among patients with CLBP at 1 outpatient clinic in Switzerland who had a pain intensity of
at least 4 on a numeric rating scale from 0 to 10. Different recruitment channels were used to enroll
patients. Data were collected fromMay 2016 to December 2017 and were analyzed from June to
November 2018.
INTERVENTIONS Patients were randomized to receive either a regular expectation briefing or a
high expectation briefing (effectiveness) and either a regular adverse side effect briefing or an
intense adverse side effect briefing (adverse side effect) in a 2 × 2 factorial design. The intervention
(briefing sessions and written materials) was standardized and delivered before the acupuncture
treatment, with additional booster informative emails provided during the 4-week, 8-session
acupuncture course.
MAINOUTCOMES ANDMEASURES The primary end point was the patients’ expectations
regarding the effectiveness of the acupuncture treatment (Expectation for Treatment Scale [ETS])
after the briefing and the subsequent pain intensity (numeric rating scale). The primary end point for
the adverse side effect briefing was the adverse side effect score at the end of the acupuncture
treatment, derived from session-by-session assessments of adverse side effects.
RESULTS A total of 152 patients with CLBP (mean [SD] age, 39.54 [12.52] years; 100 [65.8%]
women) were included. The estimated group difference (regular vs high) for the ETS was −0.16 (95%
CI −0.81 to 0.50, P = .64), indicating no evidence for a difference between intervention groups.
There was also no evidence for a difference in pain intensity at the end of the acupuncture treatment
between the groupswith different expectation briefings. The adverse side effects score in the group
with the intense adverse side effect briefing were estimated to be 1.31 times higher (95% CI, 0.94
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Abstract (continued)
to 1.82; P = .11) than after a regular adverse side effect briefing, but the finding was not statistically
significant.
CONCLUSIONS ANDRELEVANCE In this study, suggestions regarding treatment benefits (placebo)
and adverse side effects (nocebo) did not affect treatment expectations or adverse side effects.
Information regarding adverse side effects might require more research to understand nocebo
responses.
TRIAL REGISTRATION German Clinical Trials Register Identifier: DRKS00010191
JAMA Network Open. 2021;4(9):e2121418. doi:10.1001/jamanetworkopen.2021.21418
Introduction
The placebo response tomedical treatments is increasingly recognized in clinical practice,1,2 and
nocebo effects are highly prevalent in many treatments.3 Experimental studies have shown that
positive and negative suggestions can elicit placebo or nocebo effects,4,5 but physicians also
regularly use positive suggestions during consultations.6 Given that physicians also refer patients to
treatments, such as acupuncture, they inform their patients about risks and benefits. Within this
communication, clinicians aim to increase placebo effects andminimize nocebo effects.7,8
Positive messages may improve treatment outcomes9,10; therefore, studies have investigated
pretreatment briefings and specific communication styles. It was shown that additional
communication about potential benefits in patients undergoing heart surgery had a positive impact
on their disability compared with usual care, but it was not more effective than an overall supportive
communication of a similar length.11 Communicating the harms of a treatment might increase
adverse side effect reporting12; however, this needs more research. Studies using an additional
pretreatment safety briefing are still in progress.13 Studies on the adverse side effects of medication
have shownmixed results regarding the impact of the initial information on adverse side effects and
adverse side effect reporting afterwards.14
In this study, we used acupuncture as a researchmodel for a nonpharmacological intervention
because this intervention is widely available in routine care for patients with chronic low back pain
(CLBP). Physicians can inform patients about the acupuncture benefits from 2 different perspectives:
focusing either on overall effectiveness (acupuncture compared with usual care) or acupuncture-
specific effects (acupuncture compared with sham acupuncture). This researchmodel is particularly
interesting because acupuncture was found to be statistically significantly and clinically relevantly
more effective than usual care (standardizedmean difference [SMD], 0.52).15However, compared
with sham acupuncture, the association was statistically significant but not clinically relevant (SMD,
0.30).15 These 2 perspectives resulted in different recommendations in clinical practice
guidelines,16,17 followed by heterogeneous advice that physicians could provide to patients when
referring to acupuncture treatment.
Acupuncture studies have shown that patients with high expectations can have better
outcomes than patients with lower expectations.18-22 Acupuncture has served before as a suitable
placebo research model,23,24 and superficial needling of nonacupuncture points (ie, minimal
acupuncture) was more effective than no acupuncture in a randomized clinical trial.25
This study aimed to investigate the impact of 2 verbal briefing interventions on patients’
treatment expectations before minimal acupuncture treatment, the experience of adverse side
effects during treatment, and pain reduction after treatment. The verbal briefings about
acupuncture had different contents regarding effectiveness (regular vs high expectation briefings)
and adverse side effects (regular vs intense expectation briefing) of the acupuncture.
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Methods
StudyDesign
We performed a randomized single-blinded 4-armed trial with a 2 × 2 factorial design with 2
independent factors (effectiveness briefing and adverse side effect briefing plus booster emails). All
patients received a standardized 4-week minimal acupuncture treatment (8 sessions). The
standardized briefing intervention with the physician took place before the first acupuncture session
(lasting approximately 30minutes) and before the third acupuncture session (lasting approximately
15 minutes). The trial was conducted in accordance with the Declaration of Helsinki26 and the
International Conference on the Harmonisation of Good Clinical Practice. It was approved by the
cantonal ethics committee of Zurich. All participants gave written informed consent. This report
follows the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline.27 The study
protocol and the statistical analysis plan are available in Supplement 1.
The sample size calculation showed that the study needed 128 patients to have 80% power
(2-sided test; α = .05) to show a clinically meaningful effect with an SMD of 0.5 on the patients’
treatment expectations. Taking into account dropouts, 150 patients were planned (eAppendix 1 in
Supplement 2).
Participants
We included patients aged 18 to 65 years with clinically diagnosed CLBP28with an average pain
intensity of at least 4 on a numeric rating scale (NRS) from 0 to 10 and pain at least half of the days
per week in the last 6 months. Patients with an acupuncture treatment within the last 12 months
were excluded (eAppendix 2 in Supplement 2).
Study participants were recruited via email newsletters from among the staff of the University
Hospital Zurich and by flyers or emails directed at university institutions, fitness gyms, practices of
physicians, and via the institutes’ website (first patient was recruited May 5, 2016; last patient
completed the study on December 6, 2017). Interested persons could contact the study center and
participate in prescreening via telephone followed by a face-to-face consultation with a physician to
assess their final eligibility.
Briefing Interventions
The intervention (2 oral briefing sessions and writtenmaterials) was standardized and delivered by a
single study physician (M.Z.) before the treatment, followed by 2 booster emails sent after
acupuncture sessions 3 and 6. The briefing content used evidence-based information about the
effectiveness and adverse side effects of acupuncture for CLBP; however, the groups differed in the
emphasized aspects of the information (eg, positive framing in the high expectation briefings) and
the details provided (eAppendix 3 in Supplement 2). All patients were informed that they received an
acupuncture treatment that has been shown to be beneficial for CLBP. In the high expectation group,
emphasis was placed on the clinically relevant difference between acupuncture and usual care
(responder rates, 48% vs 27%) and, in the low expectation group, on the small difference between
acupuncture and sham acupuncture (responder rates, 48% vs 44%) based on the findings of an
earlier study.29
The briefing about adverse side effects was different between the regular and intense adverse
side effect communication. In the regular adverse side effect briefing group, the patients were simply
given the study information. In the intense adverse side effect briefing group, patients additionally
received a brochure that was discussed in detail with the study physician. The physician marked
typical adverse side effects (eg, bleeding, hematoma, pain) mentioned in the brochure to
emphasize them.
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Acupuncture Treatment
All patients received the same standardizedminimal acupuncture for free (8 sessions, 2 times per
week for 45minutes), which has been systematically developed25,27-30 and used in a CLBP trial
before and wasmore effective than no treatment (eAppendix 4 and eAppendix 5 in Supplement 2).
The treatmentwas delivered by 3 specially trained treatment practitioners. If required, patients could
use nonsteroidal anti-inflammatory drugs but were asked to document this in a medication diary.
Procedures
We performed central block randomization (variable block length in a 1:1:1:1 ratio, stratified by sex)
with secuTrial software (Clinical Trial Center, University Hospital Zurich). The sequence was
generated with R version 3.1.0 (R Project for Statistical Computing) by a statistician not further
involved in the study.
Before and during the study, patients were not made aware of the study aim of changing
expectations by using different verbal briefings. They were informed that the purpose of the study
was to investigate the impact of expectations on treatment effects in an observational acupuncture
study. After the end of the study, patients were fully informed and asked to provide a posttreatment
guess to measure whether the blinding of patients was successful. The publicly available information
about the study was changed after unblinding of the patients.
The physicianwas aware of the kind of briefing intervention he provided, but the acupuncturists
were blinded to the briefing allocation of the patients and were not allowed to discuss the content
of the briefing session with the patient. The statisticians were blinded to patient allocation when
analyzing the data.
Measures
For the assessment of the acupuncture treatment outcome expectation, the Expectation for
Treatment Scale (ETS) was used.31 The total score ranges from 5 to 20, with higher values indicating
higher expectation of a positive clinical outcome (Cronbach α, 0.77).
Pain intensity and pain bothersomeness were measured with an NRS32 from 0 to 10, with 0
indicating no pain or pain bothersomeness and 10 indicating worst pain or pain bothersomeness. The
pain intensity and bothersomeness both refer to the last 7 days.
Adverse side effects were assessed using a 13-item self-report questionnaire with 3 levels of
manifestation. The sum score after each acupuncture session could range from0 to 39, with higher
scores indicating more and/or stronger adverse side effects.
Self-reported health was assessed with the 29-item short-form of the Patient-Reported
Outcomes Measurement Information System (PROMIS)33with 7 PROMIS domains (ie, depression,
anxiety, physical function, pain interference, fatigue, sleep disturbance, and ability to participate in
social roles and activities) and a single item on pain intensity.34,35 The total score of each domain was
converted to a standardized T score.33
Optimism and pessimismwere assessed using the Life Orientation Test–Revised (LOT-R)36with
2 subscales (ie, optimism and pessimism). Each score can range from0 to 12, with higher values
indicating either higher optimism or pessimism (Cronbachα, optimism: 0.74; pessimism: 0.69).
To assess individuals’ sensitivity to medicines, we used the Perceived Sensitivity to Medicines
scale (PSM).37 The total score ranges between 5 and 25, with higher scores pointing toward a higher
perceived sensitivity to potential adverse side effects (Cronbach α, 0.91).
Statistical Analysis
According to the statistical analysis plan (Supplement 1), we used a hierarchical test procedure in
which the primary outcome (ETS score after the effectiveness briefing) was analyzed using analysis
of covariance (ANCOVA), with the expectation briefing group as the variable of interest and ETS
baseline and sex as covariates (eAppendix 6 in Supplement 2). In case of a statistically significant
result, the second outcome (pain intensity after theminimal acupuncture treatment) was tested as
JAMANetworkOpen | Complementary andAlternativeMedicine Effect of Briefing on Patient Expectations, Pain, and Adverse Side Effects
JAMA Network Open. 2021;4(9):e2121418. doi:10.1001/jamanetworkopen.2021.21418 (Reprinted) September 10, 2021 4/12
Downloaded From: https://jamanetwork.com/ by a UZH Hauptbibliothek / Zentralbibliothek Zuerich User  on 09/13/2021
confirmatory; otherwise, it was tested as exploratory using ANCOVA, with the expectation briefing
as the variable of interest adjusted for pain intensity at the first visit, sex, treatment practitioner, and
baseline optimism and pessimism. The adjustedmeanswith 95%CIs are reported for each treatment
group. Missing data (multiple imputations with 50 iterations according to Rubin38) were imputed
with the predictive meanmatching method in the case of continuous variables. For missing data in
binary variables, a multinomial logit model was used for factors with more than 2 levels, and an
ordered logit model was used for ordered factors (>2 levels).
For the analysis of adverse side effects, we compared the scores of each adverse side effect
briefing group (regular vs intense) after session 1 to session 7. We expected overdispersion and zero-
inflation and used a longitudinal zero-inflated negative binomial model with the adverse side effect
briefing group, sex, and time from study entry as explanatory variables as well as patient-specific
random intercepts (R package glmmTMB39). The results from the zero-inflated negative binomial
regression were reported as the ratio of adverse side effect scores (ie, as the factor by which the
adverse side effect score changes from the regular to the intense briefing) with 95%CIs and P values.
A value of 1 thus corresponds to the null hypothesis that there is no effect of the briefing on the
adverse side effect scores. All data analyses were performed using R statistical software40 version
3.6.1 with 2-sided tests. P < .05 was considered statistically significant.
Results
Overall, 471 patients were assessed for eligibility, and 152 patients were randomized to 1 of 4 groups
and analyzed (Figure). Of 152 patients (mean [SD] age, 39.54 [12.54] years), 100 (65.8%) were
women, 86 (56.6%) attended school for at least 11 years, and 63 (41.4%) had a university degree. The
4 groups showed no relevant baseline differences (Table 1).
Impact of the Briefing Interventions on Expectations and Pain
For the primary outcome of ETS score, patients in the regular expectation briefing group had an
adjusted mean score of 12.58 (95% CI, 11.86 to 13.31) compared with 12.76 (95% CI 12.02 to 13.50)
among patients in the high expectation briefing group. For pain intensity at the end of the treatment
(NRS), patients in the regular expectation briefing group had an adjustedmean score of 4.49 (95%
CI, 3.79 to 5.19) compared with 4.10 (95% CI, 3.38 to 4.82) among those in the high expectation
briefing group. There was no evidence of any differences between the 2 expectation briefing groups
for either ETS or pain intensity (Table 2). The findings for the expectation briefing did not
substantially change when the adverse side effect briefing was included in the statistical model as a
factor. At the 6-month follow-up, there was no evidence for differences in pain intensity between the
regular and high expectation briefing groups (coefficient, −0.11; 95% CI, −0.72 to 0.51; P = .73).
Impact of the Briefing Interventions onAdverse Side Effects
Patients with an intense adverse side effect briefing had a larger adverse side effects score by a factor
of 1.31 (95% CI, 0.94-1.83) compared with patients with a regular adverse side effect briefing;
however, this did not reach statistical significance (P = .11). When adjusting for sex, the estimated
means in the 2 groups were not statistically different, although patients in the intense adverse side
effects briefing group had a numerically higher number of reported adverse side effects (regular
adverse side effects briefing group: 19.25; 95% CI, 13.41-27.64; intense adverse side effects briefing
group: 25.43; 95% CI, 17.59-36.78; P = .07) (eAppendix 7 in Supplement 2). The result of the adverse
side effect briefing did not differ between first time users of acupuncture and patients with previous
acupuncture experience. No related serious adverse events were observed in any patient within
the study.
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Blinding of Patients and Treatment Practitioners
The blinding of patients and treatment practitioner was successful (Table 3). However, most patients
indicated in their posttreatment guess that they had received a regular expectation briefing.
Discussion
This study, using a routine care scenario as a researchmodel, did not confirm the hypothesis that the
pretreatment briefing intervention about the effectiveness of an acupuncture treatment influences
the treatment outcome expectations in patients with CLBP. There was no evidence that pain
intensity after treatment was influenced by the pretreatment briefing on effectiveness. There was
also no statistically significant evidence of an effect from the adverse side effect briefings; however,
the study was not powered to confirm such differences between the adverse side effect briefing
groups. For more conclusive findings, additional studies are required.
Figure. Study Flowchart
471 Patients assessed for eligibility
via telephone screening 
163 Assessed for eligibility by study 
physician
37 With data available for follow-up 35 With data available for follow-up 36 With data available for follow-up 38 With data available for follow-up
37 With data available for 6-mo 
follow-up
35 With data available for 6-mo 
follow-up
36 With data available for 6-mo 
follow-up
38 With data available for 6-mo 
follow-up
34 With data available for debriefing 34 With data available for debriefing 34 With data available for debriefing 34 With data available for debriefing
38 Analyzed 37 Analyzed 38 Analyzed 39 Analyzed
38 Randomized to and received regular
effectiveness briefing with regular 
side effects briefing
37 Randomized to and received regular
effectiveness briefing with intense 
side effects briefing
38 Randomized to and received high
effectiveness briefing with regular 
side effects briefing
39 Randomized to and received high
effectiveness briefing and intense 
side effects briefing
308 Excluded
272 Did not meet inclusion criteria
6 Declined to participate
30 Other reasons 
11 Excluded
9 Did not meet inclusion criteria
4 Other reasons
2 Declined participation
3 Use of medication
2 Pain intensity
1 Lost to follow-up 
(did not return questionnaire)
1 Lost to follow-up 
(did not return questionnaire)
1 Lost to follow-up 
(did not return questionnaire)
1 Lost to follow-up 
(did not return questionnaire)
2 Lost to follow-up 2 Lost to follow-up 1 Lost to follow-up 
(declined participation)1 Did not return questionnaire 1 Unavailable
1 Discontinued study1 Declined participation
3 Lost to debriefing
(did not return questionnaire)
3 Lost to debriefing
(did not return questionnaire)
4 Lost to debriefing
(did not return questionnaire)
152 Randomized
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One could speculate that themissing impact of the effectiveness briefing on pain might be due
to the low effectiveness of the acupuncture treatment. Comparedwith an earlier studywith a similar
setup, the magnitude of the pre-post treatment effects in our sample was very similar to the study
from which the acupuncture intervention was derived.25 Brinkhaus et al25 found a pre-post effect
Table 1. Baseline Characteristics in the 4 Treatment Conditions
Characteristic
Patients, No. (%)














Female 26 (68.4) 25 (67.6) 24 (63.2) 25 (64.1)
Male 12 (31.6) 12 (32.4) 14 (36.8) 14 (35.9)
Age, mean (SD), y 38.92 (13.60) 39.22 (10.31) 39.26 (13.46) 40.77 (12.80)
Education, No. (%)
School ≤10 y 1 (2.6) 1 (2.7) 1 (2.6) 0 (0.0)
School ≥11 y 16 (42.1) 22 (59.5) 27 (71.1) 21 (53.8)
University 21 (55.3) 14 (37.8) 10 (26.3) 18 (46.2)
Employment status
Employed 27 (71.1) 32 (86.5) 30 (78.9) 29 (74.4)
Unemployed 2 (5.3) 0 (0.0) 1 (2.6) 0 (0.0)
Student 7 (18.4) 2 (5.4) 5 (13.2) 9 (23.1)
Other 2 (5.3) 3 (8.1) 2 (5.3) 1 (2.6)
First language
German 33 (86.8) 28 (75.7) 34 (89.5) 32 (82.1)
Other 5 (13.2) 9 (24.3) 4 (10.5) 7 (17.9)
Pain, mean (SD)
Duration of pain, mo 77.50 (70.87) 98.00 (85.83) 87.63 (122.97) 122.90 (118.00)
Pain intensity, mean (SD)a 5.42 (1.45) 5.43 (1.46) 5.26 (1.16) 5.38 (1.29)
Pain bothersomeness,
mean (SD)a
5.68 (1.92) 5.38 (2.13) 5.29 (1.78) 5.56 (1.92)
No additional pain
medication
22 (57.9) 24 (64.9) 24 (63.2) 28 (71.8)




14 (36.8) 21 (56.8) 15 (39.5) 19 (48.7)
No. of sessions of last
acupuncture treatment,
mean (SD)
6.43 (6.22) 7.90 (5.73) 6.50 (4.42) 6.41 (4.15)
Success of last acupuncture
treatment, mean (SD)b
5.57 (3.08) 5.88 (3.36) 6.46 (2.99) 4.89 (3.08)
ETS, mean (SD)c 12.00 (3.20) 12.38 (3.38) 12.00 (3.54) 12.11 (2.96)
Self-reported PROMIS health
T scores, mean (SD)
Anxiety 53.57 (8.12) 54.95 (8.31) 54.07 (7.74) 55.71 (8.04)
Depression 52.08 (7.83) 51.82 (9.41) 51.77 (7.91) 53.44 (7.00)
Ability to participate in
social roles
49.30 (7.18) 47.89 (7.11) 50.16 (7.82) 48.71 (8.16)
Fatigue 54.13 (8.78) 53.28 (8.93) 54.30 (8.63) 54.86 (10.30)
Pain interference 58.56 (5.10) 58.55 (5.21) 58.39 (4.31) 58.03 (4.48)
Physical functioning 46.02 (5.99) 45.08 (5.52) 46.48 (5.03) 47.95 (5.59)
Sleep disturbance 53.03 (9.50) 52.10 (9.72) 50.28 (6.74) 50.39 (8.76)
Personality score, mean (SD)
Optimismd 8.71 (2.59) 8.51 (2.67) 8.70 (2.56) 9.03 (2.15)
Pessimismd 3.37 (2.34) 3.81 (2.09) 3.14 (2.21) 3.38 (2.55)
Perceived sensitivity
to medicinese
10.74 (5.23) 10.00 (4.67) 11.11 (5.41) 12.13 (5.17)
Abbreviations: ETS, Expectation for Treatment Scale;
PROMIS, Patient-Reported Outcomes Measurement
Information System.
a Measured on a numerical rating scale (range 0-10;
higher scores indicate more pain or
bothersomeness).
b Measured on a numerical rating scale (range 0-10;
higher scores indicating greater success).
c ETS is scored from 5 to 20, with higher scores
indicating greater expectations for success.
d Measured with the Life Orientation Test–Revised
(range, 0-12; higher scores indicate greater optimism
or pessimism).
e Measured with the Perceived Sensitivity to Medicine
(range 5-25; higher scores indicate greater perceived
sensitivity to medicine).
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size for pain intensity with an SMD of 0.96, which was comparable with the effect size (SMD, 0.91) in
our study. Therefore, we can conclude that the acupuncture treatment was implemented
successfully in our study, and themissing effect of the expectation briefing on pain intensity cannot
be explained bymissing treatment effects.
We were not able to confirm the findings of an earlier meta-analysis in pain research showing
that positive messages improved treatment outcomes (SMD, −0.31).9However, many trials included
in this meta-analysis had nonblinded treatment practitioners, and somewere not fully randomized.
After the exclusion of potentially biased trials, there was no longer any evidence of an effect.
Two trials are closely related to our investigation. An earlier study using sham acupuncture23
found an effect of communication on treatment outcomes. However, the communication in the
control group was described as limited, which raises the question of whether this kind of
communication reflects regular practice and is credible to inform routine care. A study by Suarez
et al41 also used positive suggestions during acupuncture treatment and found beneficial effects of
positive verbal suggestions. There was a statistically significant difference between acupuncture and
sham acupuncture, but the communication style had a small effect (SMD, 0.20) on the treatment
effects in both groups. This study had some similarities to our study, but it was less conceptional and
standardized, and it is unclear whether the effects could be attributed to restricted communication
or empathic communication. Our study specifically aimed to use a treatment and briefing model that
was similar to routine practice, and we used a standardized intervention tomanipulate
communication before the treatment to disentangle pretreatment and within-treatment
communication.
In our study, themagnitude of the nocebo effect of the intervention was stronger than that of
the placebo effect. This is in line with other pain studies in which the magnitude of nocebo effects
after an alteration of expectationwas large (SMD, 0.81).42However, themagnitude of nocebo effects
is variable and depends on contextual factors of the study (eg, setting, participants).43 In
experimental research, it has beenwell documented that suggestions of symptoms, a high sensitivity
to medication,44 and personality traits (ie, anxiety)45 can increase the likelihood of nocebo
responses. These findings indicate that informing patients about the adverse side effects of a
treatment might needmore attention.46 Experts have suggested that positive framing of adverse
side effects might be a suitable option within the given ethical framework.47
In placebo research, there is still a huge gap between the number of experimental studies using
suggestions and the number of studies in a real-world clinical setting using pretreatment briefing
information. Our findings imply that physicians’ communication about treatment effectiveness
Table 2. Expectation and Pain Scores for 2 Expectation Briefing Groups
Outcome






Expectation, mean (95% CI)a 12.58 (11.86-13.31) 12.76 (12.02-13.50) .60
Pain intensity (mean, 95% CI)b 4.50 (3.80-5.20) 4.12 (3.39-4.85) .23
a Expectation wasmeasured using the Expectation for
Treatment Scale (range, 5-20; higher scores indicate
greater expectations for success).
b Pain intensity was measured using a numeric rating
scale (range, 0-10; higher scores indicate more
intense pain).
Table 3. Patient and Treatment Practitioners Guesses RegardingWhich Briefing a Patient Received
vs Actual Allocation Groups
Perceived effectiveness briefing Actual effectiveness briefing received by patients, No. (%) Patients, total No.
Regular High
Regular
Patient 52 (38.5) 51 (37.8) 103
Treatment practitioner 47 (31.1) 51 (33.8) 98
High
Patient 14 (10.4) 18 (13.3) 32
Treatment practitioner 27 (17.9) 26 (17.2) 53
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before treatment may not have as much impact on treatment outcome expectations as is generally
assumed. This might be regarded by physicians as a relief given that they are already burdened with
many challenges (ie, multimorbidity, interaction effects of drugs) when seeing patients in very
limited time. However, more studies in a real-world context are necessary to providemore robust
evidence about briefings for treatment outcomes because the findings are still heterogeneous.
Considering that our study suggested a stronger influence of pretreatment information on the
nocebo response, this field should receive more attention in upcoming studies because
communication about adverse side effects is a regular task for physicians.
Strengths and Limitations
Wewould like to emphasize some important features of this study. The blinding of our treatment
practitioners is a strength because our study was able to differentiate between pretreatment
information (ie, briefing) and within-treatment communication. The treatment practitioners,
patients, and statisticians were blinded. The assessment of expectations after the briefing is an
important strength given that similar studies claimed that the change in expectations act as a
mechanism for the change in clinical outcomes, but they had not assessed expectations.41
This study also has limitations. The generalizability of our studymight be affected by the type
of study intervention, the recruitment strategy, and the rather high education level of the patients in
our sample. We conducted several sensitivity analyses to test the robustness of our findings (eg,
impact of prior acupuncture or treatment adherence on outcomes), but none of the additional
variables changed the overall findings, which could also be caused by the low sample size in
subgroups.
Conclusions
These findings indicate that briefings about treatment benefits (ie, placebo) when referring to a
treatment in routine care might not be as important as previously thought. However, information
about adverse side effects might require more research to understand nocebo responses.
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